- Home
- FG vs PTCT Comparison
FG vs PTCT Comparison
Compare FG & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FG
- PTCT
- Stock Information
- Founded
- FG 1959
- PTCT 1998
- Country
- FG United States
- PTCT United States
- Employees
- FG N/A
- PTCT N/A
- Industry
- FG Life Insurance
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- FG Finance
- PTCT Health Care
- Exchange
- FG Nasdaq
- PTCT Nasdaq
- Market Cap
- FG 4.3B
- PTCT 4.1B
- IPO Year
- FG N/A
- PTCT 2013
- Fundamental
- Price
- FG $33.82
- PTCT $60.65
- Analyst Decision
- FG Hold
- PTCT Buy
- Analyst Count
- FG 3
- PTCT 14
- Target Price
- FG $44.33
- PTCT $67.00
- AVG Volume (30 Days)
- FG 155.6K
- PTCT 1.2M
- Earning Date
- FG 11-05-2025
- PTCT 11-06-2025
- Dividend Yield
- FG 2.60%
- PTCT N/A
- EPS Growth
- FG N/A
- PTCT N/A
- EPS
- FG 2.52
- PTCT 7.72
- Revenue
- FG $5,309,000,000.00
- PTCT $1,764,929,000.00
- Revenue This Year
- FG N/A
- PTCT $119.89
- Revenue Next Year
- FG $19.65
- PTCT N/A
- P/E Ratio
- FG $13.41
- PTCT $7.88
- Revenue Growth
- FG 1.86
- PTCT 96.00
- 52 Week Low
- FG $30.01
- PTCT $33.88
- 52 Week High
- FG $50.75
- PTCT $62.18
- Technical
- Relative Strength Index (RSI)
- FG 46.48
- PTCT 69.46
- Support Level
- FG $33.23
- PTCT $58.87
- Resistance Level
- FG $34.95
- PTCT $62.18
- Average True Range (ATR)
- FG 0.71
- PTCT 2.13
- MACD
- FG -0.20
- PTCT 0.52
- Stochastic Oscillator
- FG 24.84
- PTCT 88.43
About FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.